JPRN-UMIN000014843招募中未知
The effect of L/N type Calcium channel blocker on blood pressure variability in elderly hypertensive patients - The effect of L/N type CCB on BP variability in elderly hypertensive patients
Osaka university graduate school of medicine The department of geriatric medicine and nephrology0 个研究点目标入组 40 人开始时间: 2014年8月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Secondary hypertension, malignant hypertension 2.Stroke or myocardial infarction during 6months 3.Coronary intervention during 6months 4.Congestive heart failure with NYHA class III or more 5.Aortic stenosis 6.Arterial fibrillation, arterial flutter or malignant arrhythmia 7.Severe hepatic injury 8.Sensitivity to trial drug 9.Excluded by physicians decision
研究者
相似试验
招募中
不适用
Effects of L / N type Ca channel blocker cilnicipine on heart rate and QT time during hemodialysisendstage chronic kidney diseaseJPRN-UMIN000023201Department of Nephrology and Dialysis, Moriguchi Keijinnkai Hospital20
招募中
不适用
Effect of an N/L-type Ca channel blocker on prorenin and soluble (pro)renin receptor levels in hypertensive patients: A randomized controlled trialEssential hypertensionJPRN-UMIN000016123Tokyo Women's Medical University100
招募中
不适用
Effects of the N-type Ca2+ channel blocker, Cilnidipine: Atelec®, on blood pressure levels and atherosclerosis indices in hypertensive patients with cerebrovascular disease.JPRN-UMIN000005523Ajinomoto Pharmaceuticals Co., LTD.3,000
已完成
4 期
Therapeutic effects of L/N type calcium channel blocker cilnidipine and L type calcium channel blockers on hypertensive patients with chronic kidney diseaseHypertension, Chronic kidney diseaseJPRN-UMIN000001593Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine60
招募中
不适用
Evaluation of L/N type Ca2+ channel blocker (cilnidipine) in hypertension complicated diabetes or sleep apnea syndrome ; Trial for the effects of improvementof arteriosclerosis and renal function.Diabetes/Hypertension/Sleep apnea syndromeJPRN-UMIN000014635Kanazawa Medical Clinic50